🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#sfn2024 attendees are weighing in on this year’s community poll – join the conversation at booth 1744 and be part of the movement to #EndAlz! What’s your take? #Neuroscience #AlzheimersDisease Society for Neuroscience (SfN) MODEL-AD

🚨 New Data Release Alert! 🚨 Boost your #AlzheimersDisease research with new data from the Diverse Cohorts study, gene expression from ROSMAP-IA, and RNA-seq from UCI_Trem2-R47H_NS. Don't miss out on these valuable resources – explore what’s new: news.adknowledgeportal.org/data-release-2… #EndAlz

Sign up now to learn how to work with #AlzheimersDisease data available on the Portal! This free technical workshop takes place Tuesday, 11/12 @ 1pm EST and demonstrates how to find data and conduct downstream analyses. Register here: forms.gle/VRbbTcndGRgwy2…

There's still time to sign up for the 2024 AD Knowledge Portal Technical Workshop! Don't miss this incredible opportunity to learn from the experts! forms.gle/LmFLG3wkQf9WpH…

Sign up for the #AlzheimersDisease Knowledge Portal technical workshop tomorrow at 1pm EST to learn how to find and use #OpenData available for the community! forms.gle/DV3isks8rAwyFJ… #EndAlz Friends of NIA MODEL-AD

If you missed this morning's workshop, the recording is now available on Vimeo: vimeo.com/1029001650. Follow along using the material and code on the Workshop Project on Synapse: synapse.org/Synapse:syn261… #OpenData #EndAlz MODEL-AD Friends of NIA

NOW LIVE: The AD Discovery Portal, a public facing catalog for enhanced data discovery! Designed to be open to all, the Portal allows anyone to find datasets available through AD Workbench without having to log in. Discover over 100 datasets here: discover.alzheimersdata.org

Registration is open for the TREAT-AD webinar April 29 at 1pm ET! Learn from Dr. Greg Cary of the The Jackson Laboratory about the team's in vitro screening approach to identify promising targets for #Alzheimers disease. Emory School of Medicine Structural Genomics Consortium (SGC) Sage Bionetworks us02web.zoom.us/webinar/regist…

Check out the latest #Data to advance your research in #Alzheimersdisease, with updates to human studies and several new model studies from the Mayo Clinic. For details, view Data Release 25.3: news.adknowledgeportal.org/data-release-2… #EndAlz

Just launched: the ELITE Portal!🚀A free, #OpenScience platform from Sage Bionetworks to explore exceptional longevity. Explore: 🧬Multi-omic data 🧠AI-ready tools & research 🔍Insights from The National Institute on Aging (NIA) studies Join the community to help drive #HealthyAging science! eliteportal.synapse.org

Don't miss this webinar! Sign up now to attend Evaluation of Therapeutic Hypotheses & Targets Prioritized from Systems-level Analyses of #Alzheimers disease: us02web.zoom.us/webinar/regist…

🚨NEW DATA ALERT! Data Release 25.4 includes updates to human and model studies, including new metabolomics data from the APOE-TR Study and new new plasma proteomics data from ROSMAP. For details, view Data Release 25.4 news.adknowledgeportal.org/data-release-2…

Sign up for tomorrow's webinar to explore how the TREAT-AD team is accelerating #alzheimers drug discovery! Discover how genome-wide data and in vitro screening are used to prioritize therapeutic targets for further research. #EndAlz The Jackson Laboratory us02web.zoom.us/webinar/regist…

Are you an early career scientist interested in #Alzheimers research? Apply now for the CLEAR-AD Scholars Program w/Mayo Clinic Neuro or Indiana University for hands-on experience in cutting-edge biomarker discovery, mentorship & funding to support your research! app.smartsheet.com/b/form/c9e9edc…

Missed yesterday's webinar? Catch the recording! Dr. Greg Cary of the Emory School of Medicine Sage Bionetworks Structural Genomics Consortium (SGC) The Jackson Laboratory TREAT-AD center discusses how cutting-edge systems biology can accelerate the drug development of potential therapeutic targets #EndAlz vimeo.com/1079916232